NEWS

Benefits of Using Droplet Digital PCR for Measuring Immunotherapy …
SelectScience
New research demonstrating the clinical potential of Bio-Rad ‘s Droplet Digital PCR (ddPCR) technology to measure patient response to immunotherapy was …

and more »

FDA Panel Recommends Approval for Novartis CAR–T Cell Therapy
Drug Discovery & Development
The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted to recommend approval for CTL019, an experimental cancer drug that belongs to a class of drugs called CAR T-cell therapies, which is a form of …
FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019Genetic Engineering & Biotechnology News
CAR–T gene therapy for leukemia clears FDA hurdleCBS News
Novartis’ stellar CAR–T efficacy data steamrolls safety doubts to power landmark cancer therapy toward approvalFierceBiotech
ABC News –Seeking Alpha –FDA –New York Times
all 245 news articles »

Going to the Wall Against Cancer and Apathy
Fortune
It’s to prioritize immunotherapy, which uses the immune system against cancer. Ideally it can ultimately supersede chemotherapy, radiation, and most surgeries as well as recurrences and secondary cancers, such as Good Morning America’s Robin Roberts’s, …

FDA Panel OKs First Gene Therapy For Leukemia
WebMD
WEDNESDAY, July 12, 2017 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Wednesday gave unanimous approval to what could soon be the first gene therapy to be marketed in the United States. The treatment, called CTL019, …
‘Major advance’: Leukemia treatment could be first US gene therapyUSA TODAY
Gene therapy to kill cancer moves a step closer to marketCNET
Pioneering cancer gene therapy by Novartis backed by US panelCNBC
ABC News –CBS News –Reuters –FDA
all 124 news articles »

Phase 2 Trial of Neovacs’ Lupus Interferon Immunotherapy Receives Another Review Board Sign-off
Lupus News Today
Neovacs’ Phase 2b clinical trial of an interferon immunotherapy for lupus is going according to plan, the company announced after an independent review board declined to recommend modifications to the study. The trial is evaluating interferon (IFN …

FDA panel OKs what may soon be first gene therapy approved in US
WREX-TV
(HealthDay News) — A U.S. Food and Drug Administration advisory panel on Wednesday gave unanimous approval to what could soon be the first gene therapy to be marketed in the United States. The treatment, called CTL019, genetically tweaks a patient’s …